MATERNOFETAL INTERACTION AND MODULATION IN CREATING A NEW POPULATION: A REVIEW OF CURRENT EVIDENCE ON THE RELATIONSHIP BETWEEN FETAL NUTRITION AND THE DEVELOPMENT OF CHRONIC DISEASES LATER IN LIFE

  • Ivana Novaković Klinika za ginekologiju i akušerstvo, Univerzitetski Klinički centar Srbije, Beograd, Srbija
  • Jovana Todorović Institute for social medicine, Faculty of medicine, University of Belgrade, Belgrade, Serbia
  • Stefan Dugalić Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, Belgrade, Serbia
  • Miroslava Gojnić Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, Belgrade, Serbia
Keywords: fetal programing, malnutrition, chronic diseases

Abstract


The concept of fetal programming has found its place in science and keeps lighting the way to better understanding of fetal life and its impact on postnatal and adult life. Its capacity is much wider than a common recognition of the fact that different disorders in pregnancy impact fetal health, and these capacities keep being confirmed by various observational studies and experimental models. Another fact that makes fetal programming even harder to confirm and accept is the long period between the stimulus and its consequences, as well as various factors that can change and influence this period of one’s lifetime.  Nevertheless, different hypotheses are present, concerning suboptimal fetal health and nutrition and their contribution to the development of chronic diseases during one’s lifetime - inadequate nutrition during intrauterine period and early childhood can permanently change one’s physiology and metabolism, which contributes to a possible development of chronic diseases (hypertension, coronary artery disease, stroke, diabetes, etc.). The aim of this paper is to review current evidence on the relationship between fetal nutrition and the risk of chronic diseases later in life. 

A detailed review of current literature and the analysis of various studies aimed at following neonates to their adulthood in order to determine the significance of fetal programming.

An association between suboptimal fetal growth and a higher risk of metabolic syndrome, insulin resistance, diabetes type 2, and hypertension, has been proven by the studies conducted within different populations and age groups. 

Based on the evidence presented in this paper, it can be concluded that fetal programming has been recognized as significant and is on the way to becoming the third contributing factor in the development of chronic diseases during one’s lifetime, along with a genetic predisposition and lifestyle. 

References

1. Kwon EJ, Kim YJ. What is fetal programming? a lifetime health is under the control of in utero health. Obstet Gynecol Sci. 2017 Nov;60(6):506-19. doi: 10.5468/ogs.2017.60.6.506.

2. Smith CJ, Ryckman KK. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes Metab Syndr Obes. 2015 Jun 29; 8:295-302. doi: 10.2147/DMSO.S61296.

3. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr. 1999 Feb;69(2):179-97. doi: 10.1093/ajcn/69.2.179.

4. Lucas A. Programming by early nutrition: an experimental approach. J Nutr. 1998 Feb;128(2 Suppl):401S-406S. doi: 10.1093/jn/128.2.401S.

5. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001; 60:5-20. doi: 10.1093/bmb/60.1.5.

6. Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 2: Mechanisms. Nat Rev Endocrinol. 2014 Jul;10(7):403-11. doi: 10.1038/nrendo.2014.74.

7. Seckl JR, Holmes MC. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):479-88. doi: 10.1038/ncpendmet0515.

8. Phillips DI, Walker BR, Reynolds RM, Flanagan DE, Wood PJ, Osmond C, Barker DJ, Whorwood CB. Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension. 2000 Jun;35(6):1301-6. doi: 10.1161/01.hyp.35.6.1301.

9. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004 Apr;65(4):1339-48. doi: 10.1111/j.1523-1755.2004.00511.x.

10. Langley-Evans SC. Fetal programming of cardiovascular function through exposure to maternal undernutrition. Proc Nutr Soc. 2001 Nov;60(4):505-13. doi: 10.1079/pns2001111.

11. Stocker CJ, Arch JR, Cawthorne MA. Fetal origins of insulin resistance and obesity. Proc Nutr Soc. 2005 May;64(2):143-51. doi: 10.1079/pns2005417.

12. Riveline JP, Baz B, Nguewa JL, Vidal-Trecan T, Ibrahim F, Boudou P, et al. Exposure to Glucocorticoids in the First Part of Fetal Life is Associated with Insulin Secretory Defect in Adult Humans. J Clin Endocrinol Metab. 2020 Mar 1;105(3): dgz145. doi: 10.1210/clinem/dgz145.

13. Gluckman PD. Clinical review 68: The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab. 1995 Apr;80(4):1047-50. doi: 10.1210/jcem.80.4.7714063.

14. Cianfarani S, Geremia C, Scott CD, Germani D. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr Res. 2002 Jan;51(1):94-9. doi: 10.1203/00006450-200201000-00017.

15. Renes JS, van Doorn J, Hokken-Koelega ACS. Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age. Horm Res Paediatr. 2019;92(1):15-27. doi: 10.1159/000502739.

16. Cianfarani S, Germani D, Branca F. Low birthweight and adult insulin resistance: the "catch-up growth" hypothesis. Arch Dis Child Fetal Neonatal Ed. 1999 Jul;81(1): F71-3. doi: 10.1136/fn.81.1.f71.

17. Vanhees K, Vonhögen IG, van Schooten FJ, Godschalk RW. You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring. Cell Mol Life Sci. 2014 Jan;71(2):271-85. doi: 10.1007/s00018-013-1427-9.

18. Mathews F, Yudkin P, Neil A. Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ. 1999 Aug 7;319(7206):339-43. doi: 10.1136/bmj.319.7206.339.

19. Sakali AK, Bargiota A, Fatouros IG, Jamurtas A, Macut D, Mastorakos G, Papagianni M. Effects on Puberty of Nutrition-Mediated Endocrine Disruptors Employed in Agriculture. Nutrients. 2021 Nov 22;13(11):4184. doi: 10.3390/nu13114184. 

20. Sakali AK, Papagianni M, Bargiota A, Rasic-Markovic A, Macut D, Mastorakos G. Environmental factors affecting pregnancy outcomes. Endocrine. 2023 Jun;80(3):459-469. doi: 10.1007/s12020-023-03307-9.

21. Mohanty C, Prasad R, Srikanth Reddy A, Ghosh JK, Singh TB, Das BK. Maternal anthropometry as predictors of low birth weight. J Trop Pediatr. 2006 Feb;52(1):24-9. doi: 10.1093/tropej/fmi059.

22. Todorovic J, Terzic-Supic Z, Gojnic-Dugalic M, Dugalic S, Piperac P. Sensitivity and specificity of anthropometric measures during early pregnancy for prediction of development of gestational diabetes mellitus. Minerva Endocrinol (Torino). 2021 Mar;46(1):124-6. doi: 10.23736/S2724-6507.20.03151-X.

23. Dugalic S, Petronijevic M, Vasiljevic B, Todorovic J, Stanisavljevic D, Jotic A, et al. Trends of the Prevalence of Pre-gestational Diabetes in 2030 and 2050 in Belgrade Cohort. Int J Environ Res Public Health. 2022 May 27;19(11):6517. doi: 10.3390/ijerph19116517.

24. Gojnic M, Todorovic J, Stanisavljevic D, Jotic A, Lukic L, Milicic T, et al. Maternal and Fetal Outcomes among Pregnant Women with Diabetes. Int J Environ Res Public Health. 2022 Mar 20;19(6):3684. doi: 10.3390/ijerph19063684.

25. Seneviratne SN, Rajindrajith S. Fetal programming of obesity and type 2 diabetes. World J Diabetes. 2022 Jul 15;13(7):482-97. doi: 10.4239/wjd.v13.i7.482.

26. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab. 2000 Apr;85(4):1401-6. doi: 10.1210/jcem.85.4.6544.

27. Jaquet D, Leger J, Tabone MD, Czernichow P, Levy-Marchal C. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab. 1999 Jun;84(6):1949-53. doi: 10.1210/jcem.84.6.5744.

28. Martín-Calvo N, Goni L, Tur JA, Martínez JA. Low birth weight and small for gestational age are associated with complications of childhood and adolescence obesity: Systematic review and meta-analysis. Obes Rev. 2022 Jan;23 Suppl 1: e13380. doi: 10.1111/obr.13380.

29. Motte-Signoret E, Shankar-Aguilera S, Brailly-Tabard S, Soreze Y, Dell Orto V, Ben Ammar R et al. Small for Gestational Age Preterm Neonates Exhibit Defective GH/IGF1 Signaling Pathway. Front Pediatr. 2021 Aug 10; 9:711400. doi: 10.3389/fped.2021.711400.

30. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI. Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis. Am J Physiol Endocrinol Metab. 2000 Apr;278(4): E700-6. doi: 10.1152/ajpendo.2000.278.4.E700.

31. Knop MR, Geng TT, Gorny AW, Ding R, Li C, Ley SH, et al. Birth Weight and Risk of Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension in Adults: A Meta-Analysis of 7 646 267 Participants From 135 Studies. J Am Heart Assoc. 2018 Dec 4;7(23): e008870. doi: 10.1161/JAHA.118.008870. PMID: 30486715; PMCID: PMC6405546.

32. Syddall HE, Sayer AA, Simmonds SJ, Osmond C, Cox V, Dennison EM, et al. Birth weight, infant weight gain, and cause-specific mortality: the Hertfordshire Cohort Study. Am J Epidemiol. 2005 Jun 1;161(11):1074-80. doi: 10.1093/aje/kwi137. PMID: 15901628.

33. Forsén T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med. 2000 Aug 1;133(3):176-82. doi: 10.7326/0003-4819-133-3-200008010-00008.

34. Yajnik CS. Nutrient-mediated teratogenesis and fuel-mediated teratogenesis: two pathways of intrauterine programming of diabetes. Int J Gynaecol Obstet. 2009 Mar;104 Suppl 1: S27-31. doi: 10.1016/j.ijgo.2008.11.034.

35. Singh R, Shaw J, Zimmet P. Epidemiology of childhood type 2 diabetes in the developing world. Pediatr Diabetes. 2004 Sep;5(3):154-68. doi: 10.1111/j.1399-543X.2004.00060.x.

36. Carlsson S, Persson PG, Alvarsson M, Efendic S, Norman A, Svanström L, et al. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care. 1999 Jul;22(7):1043-7. doi: 10.2337/diacare.22.7.1043.

37. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH, Knowler WC. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care. 1999 Jun;22(6):944-50. doi: 10.2337/diacare.22.6.944.

38. Olaiya MT, Wedekind LE, Hanson RL, Sinha M, Kobes S, Nelson RG, et al. Birthweight and early-onset type 2 diabetes in American Indians: differential effects in adolescents and young adults and additive effects of genotype, BMI and maternal diabetes. Diabetologia. 2019 Sep;62(9):1628-1637. doi: 10.1007/s00125-019-4899-9. 

39. Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens. 1996 Aug;14(8):935-41.

40. Alexander BT, Dasinger JH, Intapad S. Fetal programming and cardiovascular pathology. Compr Physiol. 2015 Apr;5(2):997-1025. doi: 10.1002/cphy.c140036.

41. Barker DJ, Osmond C, Simmonds SJ, Wield GA. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ. 1993 Feb 13;306(6875):422-6. doi: 10.1136/bmj.306.6875.422.

42. Kajantie E, Fall CH, Seppälä M, Koistinen R, Dunkel L, Ylihärsilä H, et al. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth. J Clin Endocrinol Metab. 2003 Mar;88(3):1059-65. doi: 10.1210/jc.2002-021380.

43. Walker BR, McConnachie A, Noon JP, Webb DJ, Watt GC. Contribution of parental blood pressures to association between low birth weight and adult high blood pressure: cross sectional study. BMJ. 1998 Mar 14;316(7134):834-7. doi: 10.1136/bmj.316.7134.834.

44. Grillo MA, Mariani G, Ferraris JR. Prematurity and Low Birth Weight in Neonates as a Risk Factor for Obesity, Hypertension, and Chronic Kidney Disease in Pediatric and Adult Age. Front Med (Lausanne). 2022 Feb 3; 8:769734. doi: 10.3389/fmed.2021.769734.

45. Bonamy AK, Norman M, Kaijser M. Being born too small, too early, or both: does it matter for risk of hypertension in the elderly? Am J Hypertens. 2008 Oct;21(10):1107-10. doi: 10.1038/ajh.2008.241.

46. Grillo MA, Mariani G, Ferraris JR. Prematurity and Low Birth Weight in Neonates as a Risk Factor for Obesity, Hypertension, and Chronic Kidney Disease in Pediatric and Adult Age. Front Med (Lausanne). 2022 Feb 3; 8:769734. doi: 10.3389/fmed.2021.769734.

Published
2023/09/27
Section
Reviews